Breast Retractors Market Size & Share 2023 to 2032

Breast Retractors Market Size

Breast Retractors Market size was valued at around USD 480 million in 2022 and is estimated to reach over USD 795.2 million by 2032. This market share is owing to factors such as technological advancements, rising incidence of breast cancer, and growing demand for cosmetic and reconstructive breast surgery among others.

The rise in breast cancer cases has significantly surged the demand for breast retractors as these devices are used in medical procedures including lumpectomies, mastectomies, and plastic surgeries. For instance, according to the World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer. The surge in breast cancer has led to a higher number of breast cancer surgeries around the globe.
 

Breast retractors are surgical instruments designed to gently hold back breast tissue, providing a clear and unobstructed view of the surgical area during breast surgeries. They are crucial tools for maintaining visibility and precision during procedures, including breast cancer surgeries, breast augmentation, and breast reconstruction.
 

The high cost associated with advanced retractors is among the major factors hampering the adoption of breast retractors in various breast procedures. Advanced breast retractors are designed with innovative features and materials to improve surgical precision, reduce tissue damage, and enhance patient outcomes. Most of these retractors are equipped with self-retaining feature to hold back breast tissue and maintain the surgical field, which reduces the need for an additional surgical assistant to keep the retractor in place. The average cost for self-retaining breast retractors ranges between USD 350 to USD 1,000. The cost differential is significant when compared to conventional alternatives like handheld breast retractors, which are priced in the range of USD 50 to USD 250.
 

COVID-19 Impact

The outbreak of COVID-19 had negatively impacted the breast retractors market revenue in 2020. The augmented demand for COVID-19 modality has significantly impacted the global aesthetic industry comprising invasive cosmetic procedures. In 2020, the incidence, as well as the mortality rate due to coronavirus was highest and people preferred to avoid any other modality procedures at healthcare facilities. The rate of breast cosmetic and reconstructive procedures reduced substantially during the COVID-impacted period worldwide. The U.S. declared a national emergency and a ban on all elective surgical and non-surgical procedures in outpatient and inpatient settings. Such variables have impacted the growth of the market in several countries across the globe.
 

Breast Retractors Market Trends

The growing demand for cosmetic and reconstructive breast surgeries has had a significant impact on the market progress across the globe. The surge in demand for breast cosmetic surgery reflects a growing interest among individuals in enhancing their appearance and self-confidence.
 

• Evolving beauty standards and the influence of media, including social media and celebrities, have led to a desire for specific body proportions and aesthetics, including well-proportioned and shapely breasts. According to according to the International Society of Aesthetic Plastic Surgery (ISAPS) survey, around 4.35 million cosmetic surgeries and procedures were performed in the U.S. in 2019, out of which 321,362 were breast augmentation procedures. These statistics underscore the enduring popularity and continued growth of cosmetic surgical options among individuals seeking to enhance their appearance and self-confidence.
   
• Moreover, advancements in surgical technologies and use of latest surgical devices such as fiber optic breast retractors have made breast procedures safer, with reduced recovery times and more natural-looking results, driving interest in these surgeries. Furthermore, improved healthcare infrastructure and increased access to surgical procedures contribute to market growth positively.
   

Breast Retractors Market Analysis

Based on type, the market is segmented as handheld and self-retaining. The handheld segment was valued at over USD 278 million. This significant market share is attributable to reduced trauma, precise tissue retraction, cost-effectiveness, and versatility among others.
 

• Handheld breast retractors come in various shapes and sizes to accommodate different breast sizes and surgical requirements. These retractors are further classified as single-arm handheld breast retractors and double-arm handheld breast retractors. The double-arm design allows for greater retraction of breast tissue, providing superior exposure to the surgical field. These are particularly beneficial in procedures where a larger area of the breast needs to be accessed.
   
• Moreover, handheld retractors are designed to minimize tissue trauma. They gently hold and separate the tissue without causing excessive damage, reducing the risk of complications, and improving post-operative healing. Overall numerous benefits related to surgical breast retractor procedures will drive the business revenue.

Learn more about the key segments shaping this market

Download Free PDF

Based on usage, the breast retractors market is segmented as reusable and disposable. The reusable breast retractors segment was valued at over USD 306.3 million. This highest market share can be attributable to several factors such as cost-effectiveness, durable construction, ease of sterilization, and customizability among others.
 

• Reusable breast retractors are built to withstand repeated sterilization cycles and heavy use. They are often constructed from durable materials like stainless steel or titanium, ensuring their longevity. The durability of reusable breast retractors contributes significantly to their long term cost-effectiveness. Unlike disposable instruments, which are discarded after a single use, these retractors can be employed across numerous surgeries without compromising their structural integrity.
   
• Moreover, these retractors are designed for efficient sterilization through autoclaving and other methods. This ensures the highest level of patient safety and compliance with healthcare regulations.

Based on application, the breast retractors market is segmented as mastectomy, breast reconstruction, breast augmentation, lumpectomy, and others. The breast augmentation segment accounted for the largest segmental share in 2022 and is anticipated to expand at 4.5% CAGR from 2023 to 2032.
 

• This dominant market share is owing to an upsurge in breast augmentation surgeries, rising awareness of cosmetic surgeries, and advancements in breast implants among others. According to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2022, breast augmentation remained the most common surgical procedure for women, with 2.2 million procedures globally and a significant increase of 29% compared to 2021. These statistics highlight the enduring popularity and growth of breast augmentation as a preferred choice for women seeking cosmetic enhancements.
   
• Moreover, continuous advancements and development in products used in these procedures are expected to aid in maintaining steady growth and continue to expand the business in the coming years.

Based on end-use, the breast retractors market is segmented as hospitals, clinics, and others. The hospital segment is projected to reach more than USD 376.3 million by 2032. The use of novel breast retractors in hospital settings offering enhanced outcomes is estimated to surge the patient preference for hospitals.
 

• Increasing admissions for breast augmentation and growing breast cancer diagnostics initiatives coupled with the availability of highly skilled healthcare professionals are some other attributes that are propelling the growth of the hospital segment positively.
   
• Furthermore, robust healthcare infrastructure and rising disposable income are anticipated to positively impact the segment growth. Individuals are increasingly inclined and financially capable of investing in elective medical procedures, including cosmetic breast surgeries that necessitate the use of breast retractors. Thus, accessibility to better treatment & diagnosis coupled with the rising breast surgery procedures is estimated to boost patient visits to hospitals, thereby propelling the segment revenue.

 

The U.S. dominated the North America breast retractors market with a significant market share in 2022 and is anticipated to expand at a considerable pace to reach around USD 321.9 million by 2032.
 

• This significant market share is attributable to several factors such as the presence of major business players, an increase in demand for the aesthetic procedures, etc. The presence of prominent players such as Medtronic plc, COOPER SURGICAL, INC., and Stryker among others are engaged in the new product development & commercialization that facilitates the industrial expansion in the country. The increasing awareness of the importance of breast health and the increasing demand for breast surgeries and related procedures has led to the growing demand for breast retractors.
   
• Additionally, technological innovations in the field of breast retractors, such as self-retaining and lighted breast retractors, have made procedures safer, less invasive, and more effective. Thus, the above-mentioned variables would augment the business growth in the U.S.
   

Breast Retractors Market Share

The breast retractors industry is fragmented in nature, with companies competing to offer superior breast retractors in this business space. Prominent players such COOPER SURGICAL, INC., Stryker, and Integra LifeSciences hold a considerable market share. These companies are diligently directing their efforts towards continuous type innovation to gain substantial market share.
 

Some of the eminent market participants operating in the breast retractors industry include:

• Medtronic plc
• COOPER SURGICAL, INC.
• Stryker
• Integra LifeSciences
• Gulmaher Surgico
• Hayden Medical Inc.
• Thompson Surgical
• Artisan Medical
• Black & Black Surgical
• Novo Surgical
   

Breast Retractors Industry News:

• In December 2022, Integra LifeSciences Holdings Corporation, a global medical technology company, announced the acquisition of Surgical Innovation Associates (SIA). This acquisition helped the company to acquire enhanced customer base.
   

Breast retractors market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Type, 2018-2032 (USD Million)

• Handheld
  • Single-arm
  • Double-arm
• Self-retaining

By Usage, 2018-2032 (USD Million)

• Reusable
• Disposable

By Application, 2018-2032 (USD Million)

• Mastectomy
• Breast Reconstruction
• Breast Augmentation
• Lumpectomy
• Other applications

By End-use, 2018-2032 (USD Million)

• Hospitals
• Clinics
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa